EveFlex

Clinical Trials

Multiple Phase III clinical trials demonstrated Evemesa's efficacy in reducing pain and inflammation in patients with osteoarthritis and rheumatoid arthritis, showing comparable efficacy to other common NSAIDs with a potentially improved gastrointestinal safety profile.

Lab Monitoring

• Complete blood count (CBC) periodically, especially with long-term use.
• Renal function tests (serum creatinine, BUN) before and during therapy.
• Liver function tests (ALT, AST) periodically, particularly in patients with pre-existing hepatic impairment.

Doctor Notes

• Prescribe the lowest effective dose for the shortest possible duration consistent with individual patient treatment goals.
• Evaluate cardiovascular risk factors and gastrointestinal bleeding risk before initiating therapy and periodically thereafter.
• Consider co-administration of a proton pump inhibitor for patients at high risk of GI complications.

Patient Guidelines

• Take Evemesa exactly as prescribed by your doctor.
• Do not exceed the recommended dose or duration of use.
• Report any signs of stomach bleeding (black stools, vomiting blood) or allergic reactions immediately.
• Inform your doctor about all other medications you are taking.

Missed Dose Advice

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.

Driving Precautions

Evemesa may cause dizziness, drowsiness, or visual disturbances in some individuals. Patients should be cautioned about driving or operating machinery if they experience these side effects.

Lifestyle Advice

• Avoid alcohol consumption while taking Evemesa to reduce the risk of stomach problems.
• Stay well-hydrated, especially if you have kidney concerns.
• For chronic pain, consider combining with non-pharmacological therapies like exercise and physical therapy.
• Do not smoke, as it can worsen gastrointestinal issues.